FTC Warns Cannabidiol Sellers to Stop Advertising CBD as a Cure to Serious Ailments
Time 1 Minute Read

The FTC teamed up with the U.S. Food and Drug Administration, sending warning letters to three companies: NutraPure, LLC, PotNetwork Holdings, Inc., and Advanced Spine and Pain LLC (d/b/a Relievus) that advertised CBD supplements as treatments for serious diseases such as cancer, Alzheimer’s disease, fibromyalgia and “neuropsychiatric disorders.” The two agencies told the companies to steer clear of false or unsubstantiated health claims and instructed the companies to notify the FTC within 15 days of the specific action taken to address the agencies’ concerns.

You May Also Be Interested In

Time 3 Minute Read

The Federal Trade Commission has issued a new Policy Statement encouraging the adoption of robust age‑verification technologies by pledging not to bring enforcement actions under the COPPA Rule against operators of general‑ or mixed‑audience sites that collect, use or disclose personal information solely to determine users’ ages, so long as long as they follow strict safeguards.

Time 1 Minute Read

On February 6, 2026, the Federal Trade Commission announced its second report to Congress on its efforts to combat ransomware and other cyber attacks.

Time 2 Minute Read

On January 28, 2026, the U.S. Federal Trade Commission held a workshop entitled “Protecting American Children: A Workshop to Explore Age Verification Technologies.”

Time 1 Minute Read

On January 28, 2026, the Federal Trade Commission will hold a public workshop on age verification technologies.

Search

Subscribe Arrow

Recent Posts

Categories

Tags

Authors

Archives

Jump to Page